The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine
Open accessAbstract
Biomarker discovery and implementation are at the forefront of the precision medicine movement. Modern advances in the field of metabolomics afford the opportunity to readily identify new metabolite biomarkers across a wide array of disciplines. Many of the metabolites are derived from or directly reflective of mitochondrial metabolism. L-carnitine and acylcarnitines are established mitochondrial biomarkers used to screen neonates for a series of genetic disorders affecting fatty acid oxidation, known as the inborn errors of metabolism. However, L-carnitine and acylcarnitines are not routinely measured beyond this screening, despite the growing evidence that shows their clinical utility outside of these disorders. Measurements of the carnitine pool have been used to identify the disease and prognosticate mortality among disorders such as diabetes, sepsis, cancer, and heart failure, as well as identify subjects experiencing adverse drug reactions from various medications like valproic acid, clofazimine, zidovudine, cisplatin, propofol, and cyclosporine. The aim of this review is to collect and interpret the literature evidence supporting the clinical biomarker application of L-carnitine and acylcarnitines. Further study of these metabolites could ultimately provide mechanistic insights that guide therapeutic decisions and elucidate new pharmacologic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 1×
“Reprogrammed metabolism, a hallmark characteristic of cancer, provides the necessary conditions for growth in substrate-dependent environments [71].”
BackgroundAdverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735 · cited 1×
“The Warburg effect, which favors glycolysis, leads to an upregulation in the compensatory pathways to fuel the TCA cycle, specifically, increased oxidation of BCAAs and fatty acids [72].”
BackgroundCYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
Calne, R. Y., Thiru, S., Mcmaster, P., Craddock, G. N., White, D. J. G., Evans, D. B., Dunn, D. C., Pentlow, B. D., & Rolles, K. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91970-0 · Cited by 1,002
Clinical pharmacokinetics and pharmacodynamics of propofol
Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0672-3 · Cited by 809
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787 · cited 1×
“The prolific metabolic switching observed in various cancers emphasizes the crucial role metabolic flexibility plays in this disease, which is reflected in the blood LC and AC profile [75].”
BackgroundMitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism
Ježek, P., & Hlavatá, L. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.013 · Cited by 744
Mihalik, S. J., Goodpaster, B. H., Kelley, D. E., Chace, D. H., Vockley, J., Toledo, F. G. S., & DeLany, J. P. (2010) · Obesity · doi:10.1038/oby.2009.510 · Cited by 653
Novel metabolic and physiological functions of branched chain amino acids: a review
Zhang, S., Zeng, X., Ren, M., Mao, X., & Qiao, S. (2017) · Journal of Animal Science and Biotechnology · doi:10.1186/s40104-016-0139-z · Cited by 639
The role of mitochondrial dysfunction in sepsis-induced multi-organ failure
Singer, M. (2014) · Virulence · doi:10.4161/viru.26907 · Cited by 617
Schooneman, M. G., Vaz, F. M., Houten, S. M., & Soeters, M. R. (2013) · Diabetes · doi:10.2337/db12-0466 · Cited by 616
Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., Hwang, D. H., Newman, J. W., & Garvey, W. T. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.103754 · Cited by 598 · cited 12×
“The authors speculated that this finding indicates mitochondrial dysfunction is minimal in the early stages of T2D.”
BackgroundInfluentialComprehensive quantification of fuel use by the failing and nonfailing human heart
Murashige, D., Jang, C., Neinast, M., Edwards, J. J., Cowan, A., Hyman, M. C., Rabinowitz, J. D., Frankel, D. S., & Arany, Z. (2020) · Science · doi:10.1126/science.abc8861 · Cited by 580
Propofol: Therapeutic Indications and Side-Effects
Marik, P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382846 · Cited by 563
Begriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., & Fromenty, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 555
An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis
Langley, R. J., Tsalik, E. L., Velkinburgh, J. C. V., Glickman, S. W., Rice, B. J., Wang, C., Chen, B., Carin, L., Suarez, A., Mohney, R. P., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005893 · Cited by 507
Metabolic response to the stress of critical illness
Preiser, J.-C., Ichai, C., Orban, J.-C., & Groeneveld, A. B. J. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu187 · Cited by 505
Kam, P. C. A., & Cardone, D. (2007) · Anaesthesia · doi:10.1111/j.1365-2044.2007.05055.x · Cited by 498
Newborn screening: toward a uniform screening panel and system—executive summary
Watson, M. S., Mann, M. Y., Lloyd-Puryear, M. A., Rinaldo, P., Howell, R. R., & American College of Medical Genetics Newborn Screening Expert Group (2006) · Pediatrics · doi:10.1542/peds.2005-2633i · Cited by 494
Carnitine and Acylcarnitines: Pharmacokinetic, Pharmacological and Clinical Aspects
Reuter, S. E., & Evans, A. M. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261931 · Cited by 493
Metabolic Inflexibility: When Mitochondrial Indecision Leads to Metabolic Gridlock
Muoio, D. M. (2014) · Cell · doi:10.1016/j.cell.2014.11.034 · Cited by 438 · cited 1×
“Increased p duction of C2 represents a critical mechanism for buffering the metabolic status between fed (glucose oxidation) and fasted (fat oxidation) states, referred to as metabolic flexibility [23,25].”
BackgroundThe significance of mitochondrial toxicity testing in drug development
Dykens, J. A., & Will, Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.013 · Cited by 416
Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
Grazioli, S., & Pugin, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00832 · Cited by 411
Impaired fatty acid oxidation in propofol infusion syndrome
Wolf, A., Weir, P., Segar, P., Stone, J., & Shield, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04064-2 · Cited by 393
Muoio, D. M., Noland, R. C., Kovalik, J.-P., Seiler, S. E., Davies, M. N., DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.005 · Cited by 372 · cited 1×
“Interestingly, there are a growing number of studies that show supplementation with LC improves glucose homeostasis through stimulation of the C2 salvage pathway that invokes metabolic flexibility [23,62,63].”
BackgroundWanders, R. J. A., Waterham, H. R., & Ferdinandusse, S. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00083 · Cited by 366 · cited 1×
“Peroxisomes utilize the carnitine shuttle to transport the end-products (acetyl-CoA, propionyl-CoA, and medium-chain acyl-CoA) into the mitochondria for complete oxidation via the TCA cycle [7,37].”
BackgroundClofazimine: current status and future prospects
Cholo, M. C., Steel, H. C., Fourie, P. B., Germishuizen, W. A., & Anderson, R. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr444 · Cited by 351
Acylcarnitines—old actors auditioning for new roles in metabolic physiology
McCoin, C. S., Knotts, T. A., & Adams, S. H. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.129 · Cited by 344
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Knottnerus, S. J. G., Bleeker, J. C., Wüst, R. C. I., Ferdinandusse, S., IJlst, L., Wijburg, F. A., Wanders, R. J. A., Visser, G., & Houtkooper, R. H. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9448-1 · Cited by 331
Ferguson, J. H. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200002000-00018 · Cited by 321
Noland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317 · cited 1×
“Interestingly, there are a growing number of studies that show supplementation with LC improves glucose homeostasis through stimulation of the C2 salvage pathway that invokes metabolic flexibility [23,62,63].”
BackgroundPharmacokinetics of L-Carnitine
Evans, A. M., & Fornasini, G. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342110-00002 · Cited by 301
Choi, Y.-M., Kim, H.-K., Shim, W., Anwar, M. A., Kwon, J.-W., Kwon, H.-K., Kim, H. J., Jeong, H., Kim, H. M., Hwang, D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135083 · Cited by 279
Metabolic aspects of peroxisomal β-oxidation
Osmundsen, H., Bremer, J., & Pedersen, J. I. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90089-z · Cited by 278
Carnitine in the treatment of valproic acid-induced toxicity
Lheureux, P. E. R., & Hantson, P. (2009) · Clinical Toxicology · doi:10.1080/15563650902752376 · Cited by 274
Hunter, W. G., Kelly, J. P., McGarrah, R. W., Khouri, M. G., Craig, D., Haynes, C., Ilkayeva, O., Stevens, R. D., Bain, J. R., Muehlbauer, M. J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003190 · Cited by 271
Chen, S., Kong, H., Lu, X., Li, Y., Yin, P., Zeng, Z., & Xu, G. (2013) · Analytical Chemistry · doi:10.1021/ac4016787 · Cited by 235
Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease
Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D. G., Reily, M. D., Lehman-McKeeman, L. D., Vaillancourt, R. R., & Cherrington, N. J. (2015) · Amino Acids · doi:10.1007/s00726-014-1894-9 · Cited by 232
So, H., Kim, H., Lee, J.-H., Park, C., Kim, Y., Kim, E., Kim, J.-K., Yun, K.-J., Lee, K.-M., Lee, H.-Y., et al. (2007) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-007-0084-9 · Cited by 230
Diabetes and branched‐chain amino acids: What is the link?: 糖尿病与支链氨基酸:有什么关联吗?
Bloomgarden, Z. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12645 · Cited by 229
Wanders, R. J. A., Ruiter, J. P. N., IJlst, L., Waterham, H. R., & Houten, S. M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9104-8 · Cited by 214
Ahmad, T., Kelly, J. P., McGarrah, R. W., Hellkamp, A. S., Fiuzat, M., Testani, J. M., Wang, T. S., Verma, A., Samsky, M. D., Donahue, M. P., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.079 · Cited by 214
Fatty acid oxidation disorders
Merritt II, J. L., Norris, M., & Kanungo, S. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.57 · Cited by 208
Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
Kaddurah-Daouk, R., & Weinshilboum, R. M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.217 · Cited by 188
Role of carnitine and its derivatives in the development and management of type 2 diabetes
Bene, J., Hadzsiev, K., & Melegh, B. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0017-1 · Cited by 186
Metabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients
Rogers, A. J., McGeachie, M., Baron, R. M., Gazourian, L., Haspel, J. A., Nakahira, K., Fredenburgh, L. E., Hunninghake, G. M., Raby, B. A., Matthay, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087538 · Cited by 178
Ferrario, M., Cambiaghi, A., Brunelli, L., Giordano, S., Caironi, P., Guatteri, L., Raimondi, F., Gattinoni, L., Latini, R., Masson, S., et al. (2016) · Scientific Reports · doi:10.1038/srep20391 · Cited by 178
Mitochondrial dysfunction in sepsis
Brealey, D., & Singer, M. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0015-9 · Cited by 177
Drug-induced mitochondrial toxicity
Chan, K., Truong, D., Shangari, N., & O’Brien, P. J. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.4.655 · Cited by 172
Zhou, L., Wang, Q., Yin, P., Xing, W., Wu, Z., Chen, S., Lu, X., Zhang, Y., Lin, X., & Xu, G. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5782-4 · Cited by 171
Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma
Li, S., Gao, D., & Jiang, Y. (2019) · Metabolites · doi:10.3390/metabo9020036 · Cited by 168
Koch-Weser, J., & Browne, T. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198003203021204 · Cited by 167
Cellular energetic metabolism in sepsis: The need for a systems approach
Carré, J. E., & Singer, M. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.04.024 · Cited by 165
Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study
Sun, L., Liang, L., Gao, X., Zhang, H., Yao, P., Hu, Y., Ma, Y., Wang, F., Jin, Q., Li, H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0232 · Cited by 164
Ruiz, M., Labarthe, F., Fortier, A., Bouchard, B., Legault, J. T., Bolduc, V., Rigal, O., Chen, J., Ducharme, A., Crawford, P. A., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00820.2016 · Cited by 164
Saiki, S., Hatano, T., Fujimaki, M., Ishikawa, K., Mori, A., Oji, Y., Okuzumi, A., Fukuhara, T., Koinuma, T., Imamichi, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06767-y · Cited by 160
Boyapati, R. K., Dorward, D. A., Tamborska, A., Kalla, R., Ventham, N. T., Doherty, M. K., Whitfield, P. D., Gray, M., Loane, J., Rossi, A. G., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy095 · Cited by 160
Mitochondrial Dysfunction and Aging: Insights from the Analysis of Extracellular Vesicles
Picca, A., Guerra, F., Calvani, R., Bucci, C., Lo Monaco, M. R., Bentivoglio, A. R., Coelho-Júnior, H. J., Landi, F., Bernabei, R., & Marzetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040805 · Cited by 159
Carnitine Inborn Errors of Metabolism
Almannai, M., Alfadhel, M., & El‐Hattab, A. W. (2019) · Molecules · doi:10.3390/molecules24183251 · Cited by 150
Batchuluun, B., Rijjal, D. A., Prentice, K. J., Eversley, J. A., Burdett, E., Mohan, H., Bhattacharjee, A., Gunderson, E. P., Liu, Y., & Wheeler, M. B. (2018) · Diabetes · doi:10.2337/db17-1150 · Cited by 148
Crosstalk between mitochondria and peroxisomes
Demarquoy, J., & Borgne, F. L. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.301 · Cited by 147
Walker, D. K. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02194.x · Cited by 145
Mechanisms of Zidovudine-Induced Mitochondrial Toxicity and Myopathy
Scruggs, E. R., & Dirks‐Naylor, A. J. (2008) · Pharmacology · doi:10.1159/000134943 · Cited by 142
The Role of Carnitine Supplementation During Valproic Acid Therapy
Raskind, J. Y., & El-Chaar, G. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19242 · Cited by 141
Prospective analysis of circulating metabolites and breast cancer in EPIC
His, M., Viallon, V., Dossus, L., Gicquiau, A., Achaintre, D., Scalbert, A., Ferrari, P., Romieu, I., Onland‐Moret, N. C., Weiderpass, E., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1408-4 · Cited by 140
Hansford, R. G., & Cohen, L. (1978) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(78)90068-1 · Cited by 131
Lipid metabolism in peroxisomes in relation to human disease
Wanders, R. J. A., & Tager, J. M. (1998) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(98)00003-x · Cited by 122
Enooku, K., Nakagawa, H., Fujiwara, N., Kondo, M., Minami, T., Hoshida, Y., Shibahara, J., Tateishi, R., & Koike, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-47216-2 · Cited by 119
Millington, D. S., Bohan, T. P., Roe, C. R., Yergey, A. L., & Liberato, D. J. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90020-8 · Cited by 117
Schroeder, M., Atherton, H. J., Dodd, M. S., Lee, P., Cochlin, L. E., Radda, G. K., Clarke, K., & Tyler, D. J. (2012) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.111.969451 · Cited by 113
Jakobs, B. S., & Wanders, R. J. A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2232 · Cited by 107
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
Wilkins, H. M., Weidling, I. W., Ji, Y., & Swerdlow, R. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00508 · Cited by 102
Inborn Errors of Metabolism with Myopathy
El‐Gharbawy, A., & Vockley, J. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.11.006 · Cited by 94
Baik, J., & Rosania, G. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047494 · Cited by 91
Self-citationChung, K., Chen, G., Chuang, T., Huang, Y., Chang, H.-T., Chen, Y., Liu, W., Chen, Y.-J., Hsu, C., Huang, M., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003517 · Cited by 89
Metabolic acidosis, rhabdomyolysis, and cardiovascular collapse after prolonged propofol infusion
Cannon, M. L., Glazier, S. S., & Bauman, L. A. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.6.1053 · Cited by 88
Kigoulet, M., Devin, A., Avéret, N., Vandais, B., & Guérin, B. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0280t.x · Cited by 87
Metabolomics as a Driver in Advancing Precision Medicine in Sepsis
Eckerle, M. D., Ambroggio, L., Puskarich, M. A., Winston, B. W., Jones, A. E., Standiford, T. J., & Stringer, K. A. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1974 · Cited by 85
Self-citationSumi, C., Okamoto, A., Tanaka, H., Nishi, K., Kusunoki, M., Shoji, T., Uba, T., Matsuo, Y., Adachi, T., Hayashi, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192796 · Cited by 85
Bruls, Y. M. H., de Ligt, M., Lindeboom, L., Phielix, E., Havekes, B., Schaart, G., Moonen‐Kornips, E., Wildberger, J. E., Hesselink, M. K. C., Muoio, D. M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.017 · Cited by 85
Zhou, L., Ding, L., Yin, P., Lu, X., Wang, X., Niu, J., Gao, P., & Xu, G. (2012) · Journal of Proteome Research · doi:10.1021/pr300683a · Cited by 82
Toxicity of valproic acid in isolated rat liver mitochondria
Jafarian, I., Eskandari, M. R., Mashayekhi, V., Ahadpour, M., & Hosseini, M. (2013) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2013.821567 · Cited by 81
A case of propofol toxicity: further evidence for a causal mechanism
Withington, D. E., Decell, M. K., & Alayed, T. M. (2004) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2004.01299.x · Cited by 79
Baik, J., Stringer, K. A., Mane, G., & Rosania, G. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01731-12 · Cited by 79
Self-citationFamularo, G., Simone, C. D., Trinchieri, V., & Mosca, L. N. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.012 · Cited by 78
Metabolic Biomarkers in Heart Failure
Albert, C. L., & Tang, W. H. W. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.08.011 · Cited by 74
Increased urinary excretion of carnitine in patients treated with cisplatin
Heuberger, W., Berardi, S., Jacky, E., Pey, P., & Krähenbühl, S. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050504 · Cited by 72
Pharmacometabolomics of l -Carnitine Treatment Response Phenotypes in Patients with Septic Shock
Puskarich, M. A., Finkel, M. A., Karnovsky, A., Jones, A. E., Trexel, J., Harris, B. N., & Stringer, K. A. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201409-415oc · Cited by 68
Self-citationToxicokinetics and Physiologically Based Toxicokinetics in Toxicology and Risk Assessment
Dixit, R., Riviere, J. E., Krishnan, K., & Andersen, M. E. (2003) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400306479 · Cited by 65
Oncometabolites as biomarkers in thyroid cancer: a systematic review
Khatami, F., Payab, M., Sarvari, M., Gilany, K., Larijani, B. A., Arjmand, B., & Tavangar, S. M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s188661 · Cited by 65
CARNITINE DEFICIENCY: A POSSIBLE MECHANISM FOR VALPROATE HEPATOTOXICITY
Coulter, D. L. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92209-8 · Cited by 63
Determination of free L-carnitine levels in type II diabetic women with and without complications
Poorabbas, A., Fallah, F., Bagdadchi, J., Mahdavi, R., Aliasgarzadeh, A., Asadi, Y., Koushavar, H., & Jabbari, M. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602594 · Cited by 63
Jones, A. E., Puskarich, M. A., Shapiro, N. I., Guirgis, F. W., Runyon, M. S., Adams, J. Y., Sherwin, R. L., Arnold, R., Roberts, B. W., Kurz, M. C., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6076 · Cited by 62
Peripheral Blood Mononuclear Cells Demonstrate Mitochondrial Damage Clearance During Sepsis
Kraft, B. D., Chen, L., Suliman, H. B., Piantadosi, C. A., & Welty‐Wolf, K. E. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003681 · Cited by 60
Using metabolomics to assess myocardial metabolism and energetics in heart failure
Turer, A. T. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.08.025 · Cited by 57
A quantitative multimodal metabolomic assay for colorectal cancer
Farshidfar, F., Kopciuk, K. A., Hilsden, R. J., McGregor, S. E., Mazurak, V. C., Buie, W. D., MacLean, A. R., Vogel, H. J., & Bathe, O. F. (2018) · BMC Cancer · doi:10.1186/s12885-017-3923-z · Cited by 56
The Effect of Valproic Acid on Plasma Carnitine Levels
Opala, G. (1991) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1991.02160090051021 · Cited by 55
Puskarich, M. A., Kline, J. A., Krabill, V. A., Claremont, H., & Jones, A. E. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113495414 · Cited by 55
Arenas, J., Huertas, R., Campos, Y., Díaz, A. E., Villalón, J. M., & Vilas, E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80246-7 · Cited by 54
Uncoupling effect of the general anesthetic 2,6-diisopropylphenol in isolated rat liver mitochondria
Branca, D., Roberti, M. S., Vincenti, E., et al. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90575-4 · Cited by 54
Biomarkers and their impact on precision medicine
Slikker, W. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217733426 · Cited by 54
Yoon, G. S., Sud, S., Keswani, R. K., Baik, J., Standiford, T. J., Stringer, K. A., & Rosania, G. R. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00035 · Cited by 47
Self-citationThe Role of the Carnitine System in Peroxisomal Fatty Acid Oxidation
Ramsay, R. R. (1999) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199907000-00005 · Cited by 47
Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter
Yao, Z., Yin, P., Su, D., Peng, Z., Zhou, L., Ma, L., Guo, W. M., Ma, L., Xu, G., Shi, J., et al. (2011) · Molecular BioSystems · doi:10.1039/c1mb05029j · Cited by 47
Propofol Related Infusion Syndrome: Ultrastructural Evidence for a Mitochondrial Disorder
Vollmer, J.-P., Haen, S., Wolburg, H., Lehmann, R., Steiner, J., Reddersen, S., Fend, F., & Fallier‐Becker, P. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002802 · Cited by 42
Carnitine supplementation for inborn errors of metabolism
Nasser, M., Barfourooshi, H. J., Fedorowicz, Z., & Noorani, Z. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006659.pub3 · Cited by 39
Thurston, J. H., & Hauhart, R. E. (1992) · Pediatric Research · doi:10.1203/00006450-199204000-00023 · Cited by 39
Puskarich, M. A., Evans, C. R., Karnovsky, A., Das, A. K., Jones, A. E., & Stringer, K. A. (2017) · Shock · doi:10.1097/shk.0000000000000997 · Cited by 34
Self-citation[Cyclosporin A causes oxidative stress and mitochondrial dysfunction in renal tubular cells].
de Hornedo, J. P., de Arriba, G., Calvino, M., Benito, S., & Parra, T. (2007) · PubMed · Cited by 34
Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism
Trexel, J., Yoon, G. S., Keswani, R. K., McHugh, C. E., Yeomans, L., Vitvitsky, V., Banerjee, R. V., Sud, S., Sun, Y., Rosania, G. R., et al. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.12.009 · Cited by 30
Self-citationKetogenesis during sepsis in relation to hepatic energy metabolism
Ohtoshi, M., JIKKO, A., Asano, M., Uchida, K., Ozawa, K., & Tobe, T. (1984) · Research in Experimental Medicine · doi:10.1007/bf01852379 · Cited by 29
Beneficial effects of l-carnitine in myoblastic C2C12 cells
Georges, B., Galland, S., Rigault, C., Borgne, F. L., & Demarquoy, J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00110-2 · Cited by 28
Carnitine Metabolism in Valproate-Treated Rats: The Effect of L-Carnitine Supplementation
Nishida, N., Sugimoto, T., Araki, A., Woo, M., Sakane, Y., & Kobayashi, Y. (1987) · Pediatric Research · doi:10.1203/00006450-198711000-00003 · Cited by 28
Variability of Mitochondrial Respiration in Relation to Sepsis-Induced Multiple Organ Dysfunction
Kohoutová, M., Dejmek, J., Tůma, Z., & Kuncová, J. (2018) · Physiological Research · doi:10.33549/physiolres.934050 · Cited by 24
Wanner, C., Schollmeyer, P. J., & Hörl, W. H. (1988) · Metabolism · doi:10.1016/0026-0495(88)90106-0 · Cited by 14
Cited by
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
Singh, A., D’Amico, D., Andreux, P. A., Fouassier, A. M., Blanco-Bose, W., Evans, M., Aebischer, P., Auwerx, J., & Rinsch, C. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100633 · Cited by 256
PFAS Exposures and the Human Metabolome: A Systematic Review of Epidemiological Studies
India-Aldana, S., Yao, M., Midya, V., Colicino, E., Chatzi, L., Chu, J., Gennings, C., Jones, D. P., Loos, R. J. F., Setiawan, V. W., et al. (2023) · Current Pollution Reports · doi:10.1007/s40726-023-00269-4 · Cited by 114
Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
Zhao, Q., Wu, Z. E., Li, B., & Li, F. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108256 · Cited by 57
Metadata
- Authors
- McCann, M. R., George De la Rosa, M. V., Rosania, G. R., & Stringer, K. A.
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2021-01-14
- Volume
- 11
- Issue
- 1
- Pages
- 51
- ISSN
- 2218-1989 (ISSN-L)
- OpenAlex
- W3120783654
- Cited by
- 327
- References
- 119
- FWCI
- 27.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.